A Phase II Study of 610 in Participants With Severe Eosinophilic Asthma
Clinical trial NCT05528679 · UNKNOWN
Trial details
- NCT number
- NCT05528679
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2023-09-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.